Join the Oncology Voice Network. Join for Free
Rethinking for Success: Top 10 Lessons for Embracing the MSL mindset through insights from Adam Grant’s “Think Again”
Think Again intellectual humility unlearning psychological safety diverse personality typesv

Rethinking for Success: Top 10 Lessons for Embracing the MSL mindset through insights from Adam Grant’s “Think Again”


Share This Article


Summary

In this episode, Tom Caravela is joined by Jeff Vaughn to explore the themes of Adam Grant's "Think Again". The discussion delves into intellectual humility, the importance of unlearning, and effective information dissemination. Tom and Jeff emphasize the value of embracing discomfort in communication and finding a balance between certainty and uncertainty. They explore the concepts of givers, takers, and matchers, offering insights into avoiding giver burnout and fostering psychological safety. The conversation also touches on the differences between education and real-world application and the importance of diverse personality types in teams. The episode concludes with reflections on the expert negotiator role and closing remarks.

This weeks guest is Jeff Vaughan, Director, North America Field Medical Science at Inizio Engage discusses Rethinking for Success: Top 10 Lessons for Embracing the MSL mindset through insights from Adam Grant’s “Think Again”.

This episode is sponsored Inizio Engage, a commercialization and strategic engagement partner for the healthcare industry, delivering solutions to meet the needs of patients, providers, payers, and pharmaceutical companies to improve the treatment experience and outcomes. Inizio creates personalized, impactful experiences and delivers an average of 5 million engagements annually across all healthcare stakeholders.

Jeff shares…

👉 Who is Adam Grant and why is this an important book
👉 What are the main areas where MSLs can “rethink” their way to success
👉 How does the book help with KOL development and relationships  
👉 How to use psychological safety and embracing uncertainty in your MSL role
👉 How to be an expert “negotiator” according to Adam Grant

Click for Source
Think Again, intellectual humility, unlearning, psychological safety, diverse personality types

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
People First… Business Second
Partner Avatar MSL Talk: Tom Caravela, Mark Freebery, Rachel Pater

People First… Business Second

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Podcast
MSL Career Options: The transition from Field Medical to Medical Director
Partner Avatar MSL Talk: Tom Caravela, Josh Corriveau

MSL Career Options: The transition from Field Medical to Medical Director

Article
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials
OVN Avatar Shubham Sharma, J Connor Wells, Wilma M Hopman, Joseph C Del Paggio, Bishal Gyawali, Nazik Hammad, Annette E Hay, Christopher M Booth

Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials

Article
CheckMate-067: Raising the Bar for the Next Decade in Oncology
OVN Avatar Sarah A. Weiss, MD, and Harriet Kluger, MD

CheckMate-067: Raising the Bar for the Next Decade in Oncology

Article
Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology
OVN Avatar Sonoko Kawakatsu, René Bruno, Matts Kågedal, Chunze Li, Sandhya Girish, Amita Joshi, Benjamin Wu

Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology

Explore OVN